Pharvaris N.V.

Pharvaris N.V.verified

PHVS

Price:

$20

Market Cap:

$1.03B

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Neth...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

PHVS

The PE Ratio as of December 2024 (TTM) for Pharvaris N.V. (PHVS) is -7.30

According to Pharvaris N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -7.30. This represents a change of 4.42% compared to the average of -6.99 of the last 4 quarters.

Pharvaris N.V. (PHVS) Historical PE Ratio (quarterly & annually)

How has PHVS PE Ratio performed in the past?

The mean historical PE Ratio of Pharvaris N.V. over the last ten years is -36.20. The current -7.30 PE Ratio has changed 1.92% with respect to the historical average. Over the past ten years (40 quarters), PHVS's PE Ratio was at its highest in in the June 2023 quarter at 163.52. The PE Ratio was at its lowest in in the December 2018 quarter at -186.63.

Quarterly (TTM)
Annual

Average

-36.20

Median

-9.66

Minimum

-186.63

Maximum

0

Pharvaris N.V. (PHVS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pharvaris N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 108.92%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -186.63

Quarterly (TTM)
Annual
YearPE RatioChange
2023-9.66108.92%
2022-4.62-48.67%
2021-9.01-67.68%
2020-27.8778.74%
2019-15.59-91.65%
2018-186.63-Infinity%

Pharvaris N.V. (PHVS) Average PE Ratio

How has PHVS PE Ratio performed in the past?

The current PE Ratio of Pharvaris N.V. (PHVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-7.76

5-year avg

-13.35

10-year avg

-36.20

Pharvaris N.V. (PHVS) PE Ratio vs. Peers

How is PHVS’s PE Ratio compared to its peers?

Pharvaris N.V.’s PE Ratio is less than PMV Pharmaceuticals, Inc. (-1.68), less than Eliem Therapeutics, Inc. (-2.42), less than MediciNova, Inc. (-0.04), less than PepGen Inc. (-2.24), less than Molecular Partners AG (-2.76), less than Mineralys Therapeutics, Inc. (-4.08), less than AN2 Therapeutics, Inc. (-0.73), less than Monte Rosa Therapeutics, Inc. (-6.35), greater than Design Therapeutics, Inc. (-7.57), less than Werewolf Therapeutics, Inc. (-1.25), less than Ikena Oncology, Inc. (-1.38), less than Stoke Therapeutics, Inc. (-6.84), greater than Tyra Biosciences, Inc. (-10.81), less than Anebulo Pharmaceuticals, Inc. (-5.07), greater than Janux Therapeutics, Inc. (-60.31), less than Rezolute, Inc. (-5.19),

Build a custom stock screener for Pharvaris N.V. (PHVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharvaris N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharvaris N.V. (PHVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharvaris N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pharvaris N.V.'s PE Ratio?

How is the PE Ratio calculated for Pharvaris N.V. (PHVS)?

What is the highest PE Ratio for Pharvaris N.V. (PHVS)?

What is the 3-year average PE Ratio for Pharvaris N.V. (PHVS)?

What is the 5-year average PE Ratio for Pharvaris N.V. (PHVS)?

How does the current PE Ratio for Pharvaris N.V. (PHVS) compare to its historical average?